Aptevo Therapeutics Raises $3 Million Through Warrant Inducement Agreement
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
What happened
Aptevo Therapeutics Inc. announced it entered into warrant inducement letter agreements with holders of its existing common warrants. Under the agreement, holders exercised their warrants for cash to purchase up to 2,777,778 shares of common stock at $1.08 per share. In exchange, Aptevo Therapeutics will issue new unregistered common stock purchase warrants. The transaction is expected to generate approximately $3.0 million in gross proceeds.
From pr-inside.com
Why it matters
The agreement allows Aptevo Therapeutics to raise capital through the exercise of existing warrants, providing funding for the clinical-stage biotechnology company. Roth Capital Partners is acting as the financial advisor for Aptevo Therapeutics in this offering.
From pr-inside.com
Who's involved
- Aptevo Therapeutics (United states)Clinical-stage biotechnology company raising capital via warrant inducement.
- ROTH Capital PartnersFinancial advisor and placement agent for Aptevo Therapeutics.
Keep exploring
The entities involved
-
ROTH Capital Partners
American small privately held investment banking company
Nothing else this week.